Eplontersen Uses, Dosage, Side Effects and more
Eplontersen is under investigation in clinical trial NCT04136184 (Neuro-ttransform: A Study to Evaluate the Efficacy and Safety of Akcea-ttr-lrx in Participants With Hereditary Transthyretin-mediated Amyloid Polyneuropathy).
| Trade Name | Eplontersen |
| Generic | AKCEA-TTR-LRx |
| AKCEA-TTR-LRx Other Names | Akcea ttr lrx, AKCEA-TTR-LRx, Eplontersen, Ion-ttr-lrx, Ionis-ttr-lrx |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
